What does QIAGEN offer for molecular diagnostics?
  • Oncology
    Learn more
    More and more oncology treatments require molecular evaluation of biomarkers either for drug prescription or treatment follow-up. Find out about our therascreen and ipsogen diagnostic assays for KRAS, EGFR, BRAF, NRAS, JAK2, BCR-ABL1, and many other biomarkers. Learn about QIAGEN technologies for mutation detection, gene expression analysis, and other topics related to oncology and companion diagnostics.
  • Infectious Disease
    Learn more
    Find out about our transplantation/immunosuppressed panel, blood-borne virus panel, and sexually transmitted disease panel, and more for pathogen testing. Check out our assays for CMV, HSV, BK virus, EBV, VZV, HIV-1, HBV, HCV, and more, including integrated automated solutions on the QIAsymphony RGQ.
  • Tuberculosis Management
    Learn more
    Discover more about our solutions for the detection of tuberculosis infection. Two different technologies – measurement of cell-mediated immune responses by T-lymphocytes and PCR assays – cover all of your clinical needs.
  • Partnering for Precision Diagnostics
    Learn more on our experience 
    QIAGEN works in partnership with pharma companies to provide programs for companion diagnostic development and global commercialization.
  • Transplantation Testing
    Learn more
    QIAGEN's integrated solutions provide the highest medical value to clinicians and patients. By incorporating new approaches to immune monitoring to existing leading nucleic acid testing, we enable valuable insights to individualize the management of transplant recipients and enable greater care.
  • Women's Health
    Learn more
    Prevention of disease is a huge focus of today's healthcare. QIAGEN offers products for the detection of human papillomavirus (HPV), Chlamydia trachomatis, and Neisseria gonorrhoeae alongside mid- to high-throughput automation. Validated sample collection, workflows, and automation provide standardized solutions for preventive testing.